Related Experiment Video

Updated: Aug 19, 2026

A Novel Method: Super-selective Adrenal Venous Sampling
06:08

A Novel Method: Super-selective Adrenal Venous Sampling

Published on: September 15, 2017

Adult height of patients with classical congenital adrenal hyperplasia

Yi-Ching Tung1, Jing-Sheng Lee, Wen-Yu Tsai

  • 1Department of Pediatrics, National Taiwan University Hospital and College of Medicine, National Taiwan University, Taipei, Taiwan.

Journal of the Formosan Medical Association = Taiwan Yi Zhi
|March 15, 2005
PubMed

Insights

Good control of disease activity and preventing precocious puberty are key for patients with classical congenital adrenal hyperplasia (CAH) to achieve normal adult height. This impacts height outcomes in CAH patients.

Area of Science:

  • Pediatric Endocrinology
  • Genetics and Genetic Diseases
  • Growth and Development

Background:

  • Classical congenital adrenal hyperplasia (CAH) is a group of inherited genetic disorders.
  • Limited data exists on factors influencing final adult height in classical CAH patients.

Purpose of the Study:

  • To investigate factors affecting the final height outcome in patients with classical CAH.
  • To analyze the impact of disease control and pubertal development on height in CAH.

Main Methods:

  • Retrospective study of 44 classical CAH patients who reached adult height without GnRH analog therapy.
  • Analysis of adult height standard deviation scores (AHSDS) and target height standard deviation scores (THSDS).
  • Evaluation of disease type, gender, disease activity control, and precocious puberty on height outcomes.

Main Results:

  • Patients with classical CAH showed a mean AHSDS-THSDS difference of -0.7 ± 1.0.
  • No significant height differences were found based on gender or CAH type.
  • Good disease control and normal puberty correlated with better height outcomes (p < 0.05).

Conclusions:

  • Classical CAH is associated with reduced adult height.
  • Effective disease activity management and prevention of precocious puberty are crucial for optimizing adult height in CAH.
  • These factors are vital for achieving near-normal adult height outcomes in individuals with classical CAH.
Abstract

More Related Videos

A Hyperandrogenic Mouse Model to Study Polycystic Ovary Syndrome08:20

A Hyperandrogenic Mouse Model to Study Polycystic Ovary Syndrome

Published on: October 2, 2018

Related Concept Videos

Nature and Nurture01:10

Nature and Nurture

Many human characteristics, like height, are shaped by both nature—in other words, by our genes—and by nurture, or our environment. For example, chronic stress during childhood inhibits the production of growth hormones and consequently reduces bone growth and height. Scientists estimate that 70-90% of variation in height is due to genetic differences among individuals, and 10-30% of variation in height is due to differences in the environments that individuals experience, such as differences...
Cushing Syndrome II: Pathophysiology01:19

Cushing Syndrome II: Pathophysiology

Cortisol production is normally governed by the hypothalamic–pituitary–adrenal (HPA) axis, which maintains hormonal balance through tightly regulated feedback mechanisms. Disruption of this regulatory system is central to the development of Cushing syndrome, whether the excess cortisol originates from external medications or internal pathology. Persistent cortisol elevation alters metabolism, immune function, and endocrine signaling, producing the characteristic clinical features of the...
Cushing Syndrome I: Introduction01:26

Cushing Syndrome I: Introduction

Cushing syndrome refers to the collection of clinical manifestations that arise when tissues are exposed to excessive amounts of cortisol or cortisol-like medications over an extended period. Cortisol, a glucocorticoid produced by the adrenal cortex, regulates metabolism, immune responses, and the body’s adaptation to stress. When its concentration remains chronically elevated, these physiological pathways become dysregulated, resulting in the characteristic features of the syndrome.Exogenous...
Polygenic Traits01:18

Polygenic Traits

When more than one gene is responsible for a given phenotype, the trait is considered polygenic. Human height is a polygenic trait. Studies have uncovered hundreds of loci that influence height, and there are believed to be many more. Due to the high number of genes involved, as well as environmental and nutritional factors, height varies significantly within a given population. The distribution of height forms a bell-shaped curve, with relatively few individuals in the population at the...
Cellular Adaptation III: Hyperplasia01:26

Cellular Adaptation III: Hyperplasia

Hyperplasia is an increase in the number of cells in a tissue or organ due to enhanced cell division. It is an adaptive, controlled response to stimuli such as injury, hormones, or stress, involving mitosis to produce genetically identical cells and support tissue repair and regeneration.Tissue CapacityCertain tissues, including the epidermis, intestinal epithelium, bone marrow, and fibroblasts, have a high potential for hyperplasia. Others, such as bone, cartilage, and smooth muscle, show...
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...